Drug Technologies in PAD: Time to Pause? - Vascular Disease Management

Drug Technologies in PAD: Time to Pause?  Vascular Disease Management

The ongoing controversy about paclitaxel-eluting devices was the subject of a debate at the Society of Interventional Radiology meeting in Austin, Texas.



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more